Ritholtz Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,166
Closed -$208K 699
2022
Q3
$208K Sell
4,166
-4,856
-54% -$269K 0.01% 647
2022
Q2
$530K Buy
9,022
+1,679
+23% +$92.6K 0.03% 305
2022
Q1
$389K Sell
7,343
-1,230
-14% -$71K 0.03% 358
2021
Q4
$520K Buy
8,573
+3,789
+79% +$225K 0.03% 295
2021
Q3
$268K Buy
+4,784
New +$263K 0.02% 396

Other funds holding PBH

Ritholtz Wealth Management's PBH Position: Q4 2022 in Review

Ritholtz Wealth Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 4,166 shares — an estimated $208K sold.

Ritholtz Wealth Management first reported a position in PBH in Q3 2021 and held it in 5 quarters. The position peaked at $530K in Q2 2022. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Ritholtz Wealth Management reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • Ritholtz Wealth Management sold 4,166 Prestige Consumer Healthcare shares in Q4 2022, an estimated $208K.
  • Ritholtz Wealth Management first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 5 quarters.
  • Ritholtz Wealth Management's Prestige Consumer Healthcare position peaked at $530K in Q2 2022.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Ritholtz Wealth Management's 13F filing for Q4 2022, filed 19 Jan 2023.